awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33397131-69A773FF-2D75-4790-8772-33A134E6C5FE
Q33397131-69A773FF-2D75-4790-8772-33A134E6C5FE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-69A773FF-2D75-4790-8772-33A134E6C5FE
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy.
P2860
Q33397131-69A773FF-2D75-4790-8772-33A134E6C5FE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-69A773FF-2D75-4790-8772-33A134E6C5FE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8e81644fc35b00d657b71d050e065d42f7329072
P2860
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.